LB Pharmaceuticals Inc Common Stock (LBRX)
LBRX Stock Price Chart
Explore LB Pharmaceuticals Inc Common Stock interactive price chart. Choose custom timeframes to analyze LBRX price movements and trends.
LBRX Company Profile
Discover essential business fundamentals and corporate details for LB Pharmaceuticals Inc Common Stock (LBRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Sept 2025
Employees
16.00
Website
https://lbpharma.usCEO
Heather D. Turner
Description
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
LBRX Financial Timeline
Browse a chronological timeline of LB Pharmaceuticals Inc Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.84.
Earnings released on 12 May 2026
EPS came in at -$0.67 surpassing the estimated -$0.75 by +10.67%.
Earnings released on 26 Mar 2026
EPS came in at -$0.45 matching the estimated -$0.45.
Earnings released on 6 Nov 2025
EPS came in at -$0.61 falling short of the estimated -$0.57 by -7.02%.
LBRX Stock Performance
Access detailed LBRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
